Vantage Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Vantage Investment Advisors's AMGN Position: Q3 2018 in Review
Vantage Investment Advisors increased its Amgen (AMGN) stake by 7.5% in Q3 2018, buying an estimated $480K and bringing the position to 34,897 shares worth $7.08M. The position accounts for 1.49% of the portfolio, ranked #26.
Vantage Investment Advisors first reported a position in AMGN in Q4 2013 and has held it in 20 quarters since. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.
- Vantage Investment Advisors held 34,897 shares of Amgen worth $7.08M as of Q3 2018.
- Vantage Investment Advisors bought 2,437 Amgen shares in Q3 2018, an estimated $480K.
- Amgen made up 1.49% of Vantage Investment Advisors's portfolio in Q3 2018, its #26 holding.
- Vantage Investment Advisors first reported a position in Amgen in Q4 2013 and has held it in 20 quarters since.
- 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.
Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.